Copyright Reports & Markets. All rights reserved.

Global Preeclampsia Diagnostics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Preeclampsia Diagnostics Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Reagent
    • 1.3.3 Instrument
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Preeclampsia Diagnostics Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Medical Center
    • 1.4.4 Other
  • 1.5 Global Preeclampsia Diagnostics Market Size & Forecast
    • 1.5.1 Global Preeclampsia Diagnostics Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Preeclampsia Diagnostics Sales Quantity (2021-2032)
    • 1.5.3 Global Preeclampsia Diagnostics Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Preeclampsia Diagnostics Product and Services
    • 2.1.4 Abbott Laboratories Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Laboratories Recent Developments/Updates
  • 2.2 ACON Laboratories, Inc.
    • 2.2.1 ACON Laboratories, Inc. Details
    • 2.2.2 ACON Laboratories, Inc. Major Business
    • 2.2.3 ACON Laboratories, Inc. Preeclampsia Diagnostics Product and Services
    • 2.2.4 ACON Laboratories, Inc. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ACON Laboratories, Inc. Recent Developments/Updates
  • 2.3 ARKRAY, Inc.
    • 2.3.1 ARKRAY, Inc. Details
    • 2.3.2 ARKRAY, Inc. Major Business
    • 2.3.3 ARKRAY, Inc. Preeclampsia Diagnostics Product and Services
    • 2.3.4 ARKRAY, Inc. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 ARKRAY, Inc. Recent Developments/Updates
  • 2.4 Bio-Rad Laboratories, Inc.
    • 2.4.1 Bio-Rad Laboratories, Inc. Details
    • 2.4.2 Bio-Rad Laboratories, Inc. Major Business
    • 2.4.3 Bio-Rad Laboratories, Inc. Preeclampsia Diagnostics Product and Services
    • 2.4.4 Bio-Rad Laboratories, Inc. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
  • 2.5 Cardinal Health
    • 2.5.1 Cardinal Health Details
    • 2.5.2 Cardinal Health Major Business
    • 2.5.3 Cardinal Health Preeclampsia Diagnostics Product and Services
    • 2.5.4 Cardinal Health Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cardinal Health Recent Developments/Updates
  • 2.6 Danaher Corporation
    • 2.6.1 Danaher Corporation Details
    • 2.6.2 Danaher Corporation Major Business
    • 2.6.3 Danaher Corporation Preeclampsia Diagnostics Product and Services
    • 2.6.4 Danaher Corporation Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Danaher Corporation Recent Developments/Updates
  • 2.7 Diabetomics, Inc.
    • 2.7.1 Diabetomics, Inc. Details
    • 2.7.2 Diabetomics, Inc. Major Business
    • 2.7.3 Diabetomics, Inc. Preeclampsia Diagnostics Product and Services
    • 2.7.4 Diabetomics, Inc. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Diabetomics, Inc. Recent Developments/Updates
  • 2.8 DIRUI Industrial Co., Ltd.
    • 2.8.1 DIRUI Industrial Co., Ltd. Details
    • 2.8.2 DIRUI Industrial Co., Ltd. Major Business
    • 2.8.3 DIRUI Industrial Co., Ltd. Preeclampsia Diagnostics Product and Services
    • 2.8.4 DIRUI Industrial Co., Ltd. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 DIRUI Industrial Co., Ltd. Recent Developments/Updates
  • 2.9 F. Hoffmann-La Roche Ltd.
    • 2.9.1 F. Hoffmann-La Roche Ltd. Details
    • 2.9.2 F. Hoffmann-La Roche Ltd. Major Business
    • 2.9.3 F. Hoffmann-La Roche Ltd. Preeclampsia Diagnostics Product and Services
    • 2.9.4 F. Hoffmann-La Roche Ltd. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
  • 2.10 Metabolomic Diagnostics Ltd.
    • 2.10.1 Metabolomic Diagnostics Ltd. Details
    • 2.10.2 Metabolomic Diagnostics Ltd. Major Business
    • 2.10.3 Metabolomic Diagnostics Ltd. Preeclampsia Diagnostics Product and Services
    • 2.10.4 Metabolomic Diagnostics Ltd. Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Metabolomic Diagnostics Ltd. Recent Developments/Updates
  • 2.11 Sera Prognostics
    • 2.11.1 Sera Prognostics Details
    • 2.11.2 Sera Prognostics Major Business
    • 2.11.3 Sera Prognostics Preeclampsia Diagnostics Product and Services
    • 2.11.4 Sera Prognostics Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sera Prognostics Recent Developments/Updates
  • 2.12 Siemens Healthineers AG
    • 2.12.1 Siemens Healthineers AG Details
    • 2.12.2 Siemens Healthineers AG Major Business
    • 2.12.3 Siemens Healthineers AG Preeclampsia Diagnostics Product and Services
    • 2.12.4 Siemens Healthineers AG Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Siemens Healthineers AG Recent Developments/Updates
  • 2.13 Other prominent players
    • 2.13.1 Other prominent players Details
    • 2.13.2 Other prominent players Major Business
    • 2.13.3 Other prominent players Preeclampsia Diagnostics Product and Services
    • 2.13.4 Other prominent players Preeclampsia Diagnostics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Other prominent players Recent Developments/Updates

3 Competitive Environment: Preeclampsia Diagnostics by Manufacturer

  • 3.1 Global Preeclampsia Diagnostics Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Preeclampsia Diagnostics Revenue by Manufacturer (2021-2026)
  • 3.3 Global Preeclampsia Diagnostics Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Preeclampsia Diagnostics by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Preeclampsia Diagnostics Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Preeclampsia Diagnostics Manufacturer Market Share in 2025
  • 3.5 Preeclampsia Diagnostics Market: Overall Company Footprint Analysis
    • 3.5.1 Preeclampsia Diagnostics Market: Region Footprint
    • 3.5.2 Preeclampsia Diagnostics Market: Company Product Type Footprint
    • 3.5.3 Preeclampsia Diagnostics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Preeclampsia Diagnostics Market Size by Region
    • 4.1.1 Global Preeclampsia Diagnostics Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Preeclampsia Diagnostics Consumption Value by Region (2021-2032)
    • 4.1.3 Global Preeclampsia Diagnostics Average Price by Region (2021-2032)
  • 4.2 North America Preeclampsia Diagnostics Consumption Value (2021-2032)
  • 4.3 Europe Preeclampsia Diagnostics Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Preeclampsia Diagnostics Consumption Value (2021-2032)
  • 4.5 South America Preeclampsia Diagnostics Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Preeclampsia Diagnostics Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Preeclampsia Diagnostics Sales Quantity by Type (2021-2032)
  • 5.2 Global Preeclampsia Diagnostics Consumption Value by Type (2021-2032)
  • 5.3 Global Preeclampsia Diagnostics Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Preeclampsia Diagnostics Sales Quantity by Application (2021-2032)
  • 6.2 Global Preeclampsia Diagnostics Consumption Value by Application (2021-2032)
  • 6.3 Global Preeclampsia Diagnostics Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Preeclampsia Diagnostics Sales Quantity by Type (2021-2032)
  • 7.2 North America Preeclampsia Diagnostics Sales Quantity by Application (2021-2032)
  • 7.3 North America Preeclampsia Diagnostics Market Size by Country
    • 7.3.1 North America Preeclampsia Diagnostics Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Preeclampsia Diagnostics Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Preeclampsia Diagnostics Sales Quantity by Type (2021-2032)
  • 8.2 Europe Preeclampsia Diagnostics Sales Quantity by Application (2021-2032)
  • 8.3 Europe Preeclampsia Diagnostics Market Size by Country
    • 8.3.1 Europe Preeclampsia Diagnostics Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Preeclampsia Diagnostics Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Preeclampsia Diagnostics Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Preeclampsia Diagnostics Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Preeclampsia Diagnostics Market Size by Region
    • 9.3.1 Asia-Pacific Preeclampsia Diagnostics Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Preeclampsia Diagnostics Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Preeclampsia Diagnostics Sales Quantity by Type (2021-2032)
  • 10.2 South America Preeclampsia Diagnostics Sales Quantity by Application (2021-2032)
  • 10.3 South America Preeclampsia Diagnostics Market Size by Country
    • 10.3.1 South America Preeclampsia Diagnostics Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Preeclampsia Diagnostics Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Preeclampsia Diagnostics Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Preeclampsia Diagnostics Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Preeclampsia Diagnostics Market Size by Country
    • 11.3.1 Middle East & Africa Preeclampsia Diagnostics Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Preeclampsia Diagnostics Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Preeclampsia Diagnostics Market Drivers
  • 12.2 Preeclampsia Diagnostics Market Restraints
  • 12.3 Preeclampsia Diagnostics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Preeclampsia Diagnostics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Preeclampsia Diagnostics
  • 13.3 Preeclampsia Diagnostics Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Preeclampsia Diagnostics Typical Distributors
  • 14.3 Preeclampsia Diagnostics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Preeclampsia Diagnostics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Preeclampsia is a specific complication of pregnancy. A systolic blood pressure of at least 140 mmHg or a diastolic blood pressure of at least 90 mmHg during pregnancy, and protein in the urine (proteinuria), both present after 20 weeks of pregnancy, is diagnostic. If only new-onset hypertension, It is called gestational hypertension (without proteinuria or other signs of organ infection). Before the 20th week of pregnancy, some women develop high blood pressure, which is called chronic hypertension. Preeclampsia and chronic hypertension are common hypertensive problems during pregnancy. Preeclampsia usually presents in the third trimester with few symptoms.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Preeclampsia Diagnostics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Preeclampsia Diagnostics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Preeclampsia Diagnostics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Preeclampsia Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Preeclampsia Diagnostics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Preeclampsia Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Preeclampsia Diagnostics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health, Danaher Corporation, Diabetomics, Inc., DIRUI Industrial Co., Ltd., F. Hoffmann-La Roche Ltd., Metabolomic Diagnostics Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Preeclampsia Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Reagent
    Instrument
    Market segment by Application
    Hospital
    Medical Center
    Other
    Major players covered
    Abbott Laboratories
    ACON Laboratories, Inc.
    ARKRAY, Inc.
    Bio-Rad Laboratories, Inc.
    Cardinal Health
    Danaher Corporation
    Diabetomics, Inc.
    DIRUI Industrial Co., Ltd.
    F. Hoffmann-La Roche Ltd.
    Metabolomic Diagnostics Ltd.
    Sera Prognostics
    Siemens Healthineers AG
    Other prominent players
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Preeclampsia Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Preeclampsia Diagnostics, with price, sales quantity, revenue, and global market share of Preeclampsia Diagnostics from 2021 to 2026.
    Chapter 3, the Preeclampsia Diagnostics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Preeclampsia Diagnostics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Preeclampsia Diagnostics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Preeclampsia Diagnostics.
    Chapter 14 and 15, to describe Preeclampsia Diagnostics sales channel, distributors, customers, research findings and conclusion.

    Buy now